Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
As Eli Lilly And Co (NYSE: LLY ) prepares to report third-quarter results in late October, Guggenheim analyst Seamus Fernandez maintains a Buy rating, with a raised price target from $1,273 to $1,284. While the company’s U.S. tirzepatide franchise remains strong, Fernandez says Foundayo’s trajectory is promising, with
Oracle is set to report first-quarter results Thursday after the close, with analysts watching cloud growth, financing plans, OpenAI ties and data-center capacity against expectations for revenue of $19.14 billion and EPS of $1.74.
Hammerstone MarketTalk reports that GUGG raised its price target on S from $24 to $28 while maintaining a Buy rating.